Prochlorperazine Edisylate Injection, Solution
Product Images NDC 83634-778

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 83634-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pro2d 0002 01)

Chemical structure diagram of prochlorperazine edisylate showing the molecular arrangement including piperazine and phenothiazine ring systems with sulfonate groups.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL – Vial Label)

Label for Prochlorperazine Edisylate Injection USP, 10 mg per 2 mL (5 mg per mL) solution. Intended for deep intramuscular or intravenous use. The label notes it is not for subcutaneous use and contains a 2 mL multi-dose vial. Manufactured by Avenacy Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.